Full title: Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen (CHONQUER)
Age: 18+
Locations:
- Edinburgh – Western General Hospital
- London – The Royal Marsden, University College London Hospital
- Manchester – Christie Hospital
- Oxford – Churchill Hospital
Brief summary:
Chonquer is a phase III is an international clinical trial examining a ivosidenib as a treatment option for people with locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 systemic treatment regimen.
More information can be found at clinicaltrials.gov and on the CHONQUER trial website.
To find out more about this trial and whether you could take part, talk to your clinical team.
